Article Text

Original research
Evaluating access to health and care services during lockdown by the COVID-19 survey in five UK national longitudinal studies
  1. Constantin-Cristian Topriceanu1,2,
  2. Andrew Wong2,
  3. James C Moon3,4,
  4. Alun D Hughes1,2,
  5. David Bann5,
  6. Nishi Chaturvedi1,2,
  7. Praveetha Patalay2,5,
  8. Gabriella Conti6,
  9. Gaby Captur1,2,7
  1. 1School of Medicine, University College London, London, UK
  2. 2UCL MRC Unit for Lifelong Health and Ageing, University College London, London, UK
  3. 3Institute of Cardiovascular Science, University College London, London, UK
  4. 4Cardiac Imaging Department, Barts Heart Center, London, UK
  5. 5Center for Longitudinal Studies, Department of Social Science, University College London, London, UK
  6. 6Department of Economics and UCL Social Research Institute, University College London, London, UK
  7. 7Center for Inherited Heart Muscle Conditions, Cardiology Department, The Royal Free Hospital, London, UK
  1. Correspondence to Dr Gaby Captur; gabriella.captur{at}ucl.ac.uk

Abstract

Objective Access to health services and adequate care is influenced by sex, ethnicity, socioeconomic position (SEP) and the burden of comorbidities. Our study aimed to assess whether the COVID-19 pandemic further deepened these already existing health inequalities.

Design Cross-sectional study.

Setting Data were collected from five longitudinal age-homogenous British cohorts (born in 2000-2002, 1989-1990, 1970, 1958 and 1946).

Participants A web survey was sent to the cohorts. Anybody who responded to the survey was included, resulting in 14 891 eligible participants.

Main outcomes measured The survey provided data on cancelled surgical or medical appointments, and the number of care hours received in a week during the first UK COVID-19 national lockdown.

Interventions Using binary or ordered logistic regression, we evaluated whether these outcomes differed by sex, ethnicity, SEP and having a chronic illness. Adjustment was made for study design, non-response weights, psychological distress, presence of children or adolescents in the household, COVID-19 infection, key worker status, and whether participants had received a shielding letter. Meta-analyses were performed across the cohorts, and meta-regression was used to evaluate the effect of age as a moderator.

Results Women (OR 1.40, 95% CI 1.27 to 1.55) and those with a chronic illness (OR 1.84, 95% CI 1.65 to 2.05) experienced significantly more cancellations during lockdown (all p<0.0001). Ethnic minorities and those with a chronic illness required a higher number of care hours during the lockdown (both OR≈2.00, all p<0.002). SEP was not associated with cancellation or care hours. Age was not independently associated with either outcome in the meta-regression.

Conclusion The UK government’s lockdown approach during the COVID-19 pandemic appears to have deepened existing health inequalities, impacting predominantly women, ethnic minorities and those with chronic illnesses. Public health authorities need to implement urgent policies to ensure equitable access to health and care for all in preparation for a fourthwave.

  • epidemiology
  • quality in health care
  • public health
https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Twitter @CTopriceanu

  • Contributors CCT analysed the data and wrote the manuscript. CCT, JCM, ADH, DB, NC, PP, GCo and GCa were involved in the study design and implementation. AW, ADH, DB, NC, PP and GCo actively participated in the data acquisition. GCa contributed to the data analysis, interpretation of the results and manuscript drafting; was the guarantor of this work; and attested that all listed authors met the authorship criteria and that no others meeting the criteria were omitted. All authors were involved in critically revising the manuscript and approving the final version.

  • Funding The study was funded by the Economic and Social Research Council under the Center for Longitudinal Studies, Resource Center 2015–2020 (grant number ES/M001660/1) and by the Medical Research Council (grant MC_UU_00019/1). GCa is supported by British Heart Foundation (MyoFit46 Special Programme Grant SP/20/2/34841), the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC) and by the NIHR UCL Hospitals Biomedical Research Center. JCM is directly and indirectly supported by the UCL Hospitals NIHR BRC and Biomedical Research Unit at Barts Hospital, respectively. DB is supported by the Economic and Social Research Council (grant number ES/M001660/1) and by The Academy of Medical Sciences/Wellcome Trust (Springboard Health of the Public in 2040 award: HOP001/1025). AH receives support from the British Heart Foundation, the Economic and Social Research Council, the Horizon 2020 Framework Programme of the European Union, the National Institute on Aging, the National Institute for Health Research University College London Hospitals Biomedical Research Center, and the UK Medical Research Council and works in a unit that receives support from the UK Medical Research Council. GCo thanks for support the European Research Council under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 819752 DEVORHBIOSHIP–ERC-2018-COG).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval Ethical approval was obtained from relevant committees and from the University College London/Institute of Education research ethics committee (REC1334). All participants gave informed consent before taking part in the study.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon reasonable request. NSHD data are available online (https://www.nshd.mrc.ac.uk/data). Data from the remaining cohorts are available from the UK Data Archive (https://www.data-archive.ac.uk).

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.